Decrease in catalytic capacity of γ-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular and cellular neurosciences

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mcn.2015.06.002PMID 26051801
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrating the molecular and the population approaches to dementia research to help guide the future development of appropriate therapeutics.

  2014cited by this paper
• DNMT1-interacting RNAs block gene specific DNA methylation

  2013cited by this paper
• Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers

  2013influential reference
• Aftins Increase Amyloid-β42, Lower Amyloid-β38, and Do Not Alter Amyloid-β40 Extracellular Production in vitro: Toward a Chemical Model of Alzheimer's Disease?

  2013cited by this paper
• The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD

  2013cited by this paper
• Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease

  2013influential reference
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Modulation of γ-Secretase Activity by Multiple Enzyme-Substrate Interactions: Implications in Pathogenesis of Alzheimer's Disease

  2012influential reference
• Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice

  2012influential reference
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012influential reference
• Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of γ-secretase activity in endogenous amyloid-β generation.

  2012influential reference
• The mechanism of γ-Secretase dysfunction in familial Alzheimer disease

  2012influential reference
• Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers.

  2012influential reference
• Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia

  2012cited by this paper
• Interplay between α-, β-, and γ-Secretases Determines Biphasic Amyloid-β Protein Level in the Presence of a γ-Secretase Inhibitor

  2012cited by this paper
• Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease

  2012cited by this paper
• Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia

  2012influential reference
• Targets for AD treatment: conflicting messages from γ‐secretase inhibitors

  2011influential reference
• Alzheimer’s Disease: The Challenge of the Second Century

  2011cited by this paper
• Molecular and Cellular Neuroscience

  2009cited by this paper
• MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1*

  2009cited by this paper
• The unsolved relationship of brain aging and late-onset Alzheimer disease.

  2009influential reference
• γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s Disease

  2009influential reference
• Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants

  2008influential reference
• Mammalian cytosine DNA methyltransferase Dnmt1: enzymatic mechanism, novel mechanism-based inhibitors, and RNA-directed DNA methylation.

  2008cited by this paper
• Mammalian Cytosine DNA Methyltransferase Dnmt 1 : Enzymatic Mechanism , Novel Mechanism-Based Inhibitors , and RNA-directed DNA Methylation

  2008cited by this paper
• The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

  2008cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008cited by this paper
• The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression*

  2008influential reference
• Variations in the APP gene promoter region and risk of Alzheimer disease

  2007cited by this paper
• {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE.

  2007cited by this paper
• The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism

  2007influential reference
• γ-Secretase Substrate Concentration Modulates the Aβ42/Aβ40 Ratio

  2007cited by this paper
• APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage

  2007cited by this paper
• Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms

  2006influential reference
• APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

  2006cited by this paper
• Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila.

  2006influential reference
• Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase.

  2006cited by this paper
• Down-regulation of Endogenous Amyloid Precursor Protein Processing due to Cellular Aging*

  2006influential reference
• Mean age‐of‐onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40

  2006influential reference
• Equimolar Production of Amyloid β-Protein and Amyloid Precursor Protein Intracellular Domain from β-Carboxyl-terminal Fragment by γ-Secretase*

  2006cited by this paper
• Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting.ByHarvey Motulskyand, Arthur Christopoulos.Oxford and New York: Oxford University Press. $65.00 (hardcover); $29.95 (paper). 351 p; ill.; index. ISBN: 0–19–517179–9 (hc); 0–19–517180–2 (pb). 2

  2005influential reference
• DNA cytosine C5 methyltransferase Dnmt1: catalysis-dependent release of allosteric inhibition.

  2005cited by this paper
• Mechanism of allosteric regulation of Dnmt1's processivity.

  2005cited by this paper
• Increased β‐Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects

  2004cited by this paper
• Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.

  2004influential reference
• [Amyloid beta peptide].

  2004cited by this paper
• Beta-secretase activity increases with aging in human, monkey, and mouse brain.

  2004influential reference
• Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting

  2004influential reference
• Mouse Models of Alzheimer's Disease: Insight into Treatment

  2004cited by this paper
• Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients

  2004cited by this paper
• APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity.

  2003cited by this paper
• Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression.

  2003influential reference
• APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity

  2003cited by this paper
• Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

  2003cited by this paper
• Localization of β-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls

  2002cited by this paper
• Antisense‐Induced Reduction of Presenilin 1 Expression Selectively Increases the Production of Amyloid β42 in Transfected Cells

  1999cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993influential reference
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992influential reference
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992influential reference

• Computational Based Identified EAAT2 Transporter Activator Attenuates Amyloid‐β Induced Excitotoxicity in Primary Neuronal‐Astroglial Mixed Culture by Ameliorating Glutamate Clearance

  2026cites this paper
• Nonallosteric activation of posttranslational modification enzymes by active site-directed inhibitors

  2023cites this paper
• The Binding of Different Substrate Molecules at the Docking Site and the Active Site of γ-Secretase Can Trigger Toxic Events in Sporadic and Familial Alzheimer’s Disease

  2022influential citation
• Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer’s Disease

  2021influential citation
• Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues

  2020cites this paper
• Structural Analysis of Simultaneous Activation and Inhibition of γ-Secretase Activity in Development of Drugs for Alzheimer’s disease

  2020cites this paper
• [Progress on loss-of-function hypothesis of presenilin-1 mutations in Alzheimer diseases].

  2020cites this paper
• High-throughput Virtual Screening Web Service Development for SARS-CoV-2 Drug Design

  2020cites this paper
• Can Anti–β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?

  2020cites this paper
• Novel presenilin 1 mutation (p.Thr-Pro116-117Ser-Thr) in a Spanish family with early-onset Alzheimer's disease.

  2019cites this paper
• Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

  2018cites this paper
• Presenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development

  2018cites this paper
• NeuronRead, an open source semi‐automated tool for morphometric analysis of phase contrast and fluorescence neuronal images

  2017cites this paper
• In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1

  2017cites this paper
• Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer’s Disease

  2016cites this paper
• Alpha-synuclein expression influences the processing of the amyloid precursor protein

  2016cites this paper
• Genetic Variations: Heroes or Villains

  2016cites this paper